CanSino, New Oriental unit pave way for HK floats
CanSino Biologics, founded by a group of Chinese vaccination industry experts from Canada, has filed for a listing in Hong Kong.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts